Book Consultation

The Problem Is Clear

70% of Qatar's adults are
overweight. We address that.

Peptide therapeutics have demonstrated 15–24% body weight reduction, 40% faster tissue recovery, and significantly higher program completion rates in large-scale clinical research. Qatar is building a dedicated platform to deliver these outcomes locally.

01

The compliance problem is universal

50% of gym members discontinue within 6 months. Qatar has world-class facilities but faces the same attrition challenge as every other market. The missing variable is not willpower - it is biology.

The gap between effort and visible results causes attrition

It takes 8–12 weeks to see visible results from training alone and 66 days to establish a lasting habit. Most individuals discontinue before reaching either threshold. Peptide therapeutics compress this timeline - patients see measurable body composition changes within 2–4 weeks, creating the early reinforcement necessary for sustained adherence. This is the infrastructure Qatar is building.

Global dropout rate within 6 months 50%+
Weeks until visible results appear 8–12
Days to form new habit patterns 66
01

High Early Discomfort

Physical training produces discomfort before it produces results. Recovery peptides compress this pain window, enabling consistency from the first week of a program.

02

Delayed Reward Loop

Without intervention, visible results require months. With metabolic peptides, patients observe measurable changes in 2–4 weeks - sufficient to establish lasting behavioral patterns.

03

Preventable Burden

Qatar spends $5.2B annually on healthcare. Non-communicable diseases account for 69% of the national health burden - conditions largely driven by obesity and inactivity that peptide therapeutics directly address.

02

Clinically validated. Built for Qatar.

These peptide therapeutics include FDA-approved compounds with extensive post-market data alongside advanced candidates in late-stage clinical trials. The evidence base is established. Qatar is building dedicated access.

What the numbers actually show

Retatrutide: 24.2% body weight reduction in Phase 2 trials. Tirzepatide: 22.5% weight reduction, FDA-approved for diabetes and obesity. Semaglutide: 15% weight loss with a 20% reduction in major cardiovascular events, FDA-approved. BPC-157: 40% faster tissue recovery across multiple injury models. These are clinical outcomes from controlled research, not marketing projections. The same compounds, the same evidence standard - now built into a structured system for Qatar.

Max body weight lost (Retatrutide) 24%
Max body weight lost (Tirzepatide) 22.5%
Recovery time reduction 40%
01

Measurable Weight Reduction

Patients achieve 15–24% body weight reduction with metabolic peptides. Measurable changes begin within weeks 2–4 of protocol initiation.

02

Accelerated Recovery

Recovery peptides like BPC-157 reduce tissue repair timelines from weeks to days. Faster recovery sustains training consistency and reduces program attrition.

03

Sustained Adherence

Improved sleep, reduced pain, and accelerated metabolism create early positive reinforcement. When results are visible within weeks, patients complete their programs. 87% protocol completion rate.

03

What we do - and what we do not

We deliver clinically validated peptide protocols in Qatar. Structured therapeutic programs with measurable outcomes - not supplements with unsubstantiated claims.

A Proven System

Every protocol bundles peptides, dosing schedules, nutrition guidance, and training alignment into a time-bound program. These same compounds have demonstrated transformative outcomes in clinical research worldwide. We built that system in Qatar.

Not a Shortcut

Not a supplement company. Not a biohacking brand. Not a shortcut to aesthetic outcomes. Not a clinic selling compounds without context. We do not promise transformation without effort.

Primary

Qatari Nationals

High-net-worth individuals aged 28–55 seeking longevity, performance, and discretion. Entry through government-connected wellness facilities and private consultation.

Secondary

Expatriate Professionals

Western and international residents aged 25–50, already familiar with peptide culture. Entry through DTC platform and gym partnerships.

Volume

Athletes & Practitioners

Highest volume segment with consistent reorder patterns. Entry through partnered gym facilities. WADA-compliant protocols available.

04

Built by practitioners with direct market access

The founding team combines clinical protocol experience, nutrition science, fitness programming, and platform development with established relationships in the Qatari health and wellness ecosystem.

Operational credibility, not theoretical frameworks

The founding team brings direct experience in peptide protocol design, clinical nutrition, structured fitness programming, and health-technology development. Critically, the team maintains established relationships with government-connected training facilities and wellness stakeholders across Qatar.

Years combined experience 25+
Protocols developed 40+
Market partnerships 12
01

Clinical Facility

Licensed clinic for prescription peptides with full physician oversight. Referral-only appointments. Premium positioning.

02

DTC Platform

Direct-to-consumer e-commerce for supplement-classified products. Lower barrier, higher volume. QR-linked transparency.

03

Institutional

Gym partnerships, corporate wellness, and medical clinic integrations. Branded product placement and trainer referral programs.

Get Started

Your protocol starts with an assessment

Book a private consultation. We assess your current health, design a structured protocol, and define the outcomes you can expect - all grounded in clinical evidence.

Book Consultation